Basic Information
| LncRNA/CircRNA Name | NR_038435 |
| Synonyms | HOXD-AS2 |
| Region | GRCh38_2:176121611-176137098 |
| Ensemble | ENSG00000237380 |
| Refseq | NR_038435 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | Cisplatin | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | ovarian cancer |
| ICD-0-3 | C56.9 |
| Methods | Microarray, qPCR etc. |
| Sample | cell lines (A2780, CP70, SKOV3, and SKOV3/DDP) |
| Expression Pattern | down-regulated |
| Function Description | The lncRNA microarray analysis and qPCR identified seven lncRNAs that were significantly downregulated. |
| Pubmed ID | 28128423 |
| Year | 2017 |
| Title | Long non-coding RNA ENST00000457645 reverses cisplatin resistance in CP70 ovarian cancer cells. |
External Links
| Links for NR_038435 | GenBank HGNC NONCODE |
| Links for ovarian cancer | OMIM COSMIC |